DCDT2980S
DCDT2980S Uses, Dosage, Side Effects, Food Interaction and all others data.
DCDT2980S is under investigation in clinical trial NCT01691898 (A Study of Pinatuzumab Vedotin (DCDT2980S) Combined With Rituximab or Polatuzumab Vedotin (DCDS4501A) Combined With Rituximab or Obinutuzumab in Participants With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)).
| Trade Name | DCDT2980S |
| Generic | Pinatuzumab vedotin |
| Pinatuzumab vedotin Other Names | DCDT2980S, Pinatuzumab vedotin |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here DCDT2980S
